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Cyclosporin A inhibits apical secretory K channels in rabbit
cortical collecting tubule principal cells
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Cyclosporin A inhibits apical secretory K' channels In rabbit cortical
collecting tubule principal cells. We used the cell-attached patch clamp
configuration to examine the effect of basolateral cyclosporin A (CsA)
exposure on low conductance K' channels found in the principal cell
apical membrane of rabbit cortical collecting tubule (CCT) primary
cultures. Baseline K channel activity, measured as mean NP0 (number
of channels x open probability), was 2.7 1.1 (N = 29). NP0 fell by
69% (0.84 0.32; N = 32) in cultures pretreated with 500 ng/ml CsA for
30 minutes prior to patching, Chelation of intracellular [Ca21']1 (10 mM
BAPTA/AM; N = 8) or removal of extracellular Ca2" (N = 9), but not
prevention of [Ca2"]1 store release (10 M TMB-8; N = 7), abolished
CsA-induced inhibition. This suggested that CsA effects were mediated
by an initial rise in [Ca21'], via Ca2" influx. Either 25 nM AVP (N = 10)
or 0.25 M thapsigargin (N = 8) (causing 1P3-dependent and -indepen-
dent release of [Ca2"] stores, respectively) augmented, while 25 M (N
6) or 250 M AVP (N = 8) reversed CSA-induced channel inhibition.
Apical membrane protein kinase C (PKC) activation with 0.1 M
phorbol ester, PMA (N = 8) or 10 ftM synthetic diacylglycerol, OAG (N
= 7), mimicked (mean NP0 = 0.99 0.40) the inhibitory effect of CsA.
Apical PKC inhibition by prolonged apical exposure to PMA (N = 10)
or 100 ILM D-sphingosine (N = 6) blocked CsA's effect. Cyclic AMP
increasing maneuvers, 10 /LM forskolin (N = 5) or 0.5 m db-cAMP (N
= 8), stimulated basal K1' channel activity in the absence of CsA. In
Conclusion: (1) basolateral exposure to CsA inhibits the activity of
apical membrane 13 pS channels responsible for physiologic K"' secre-
tion in rabbit CCI principal cells. (2) The inhibition is mediated by
changes in intracellular Ca2" and activation of apical PKC. (3) Phar-
macologic AVP (nM) augments CsA-induced inhibition by releasing
intracellular Ca2 stores; more physiologic AVP (pM) attenuates chan-
nel inhibition, probably through cAMP generation. (4) Inhibition of
apical secretory K1' channels by CsA likely contributes to decreased
kaliuresis and clinical hyperkalemia observed in patients on CsA
therapy.
Cyclosporin A (CsA) is a cyclic peptide widely used in the
prevention and treatment of organ transplant rejection and
other autoimmune disorders [1, 2]. CsA nephrotoxicity contin-
ues to be the most important complication limiting the clinical
use of this immunosuppressive drug. Human and animal studies
have demonstrated decreased kaliuresis and urinary acidifica-
tion with CsA exposure, suggesting that the drug may interfere
with distal nephron ion transport [3—6]. Hyperkalemia is a
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common manifestation in patients receiving CsA therapy, but
the pathophysiology is not well understood [7].
The renal epithelial K1' transport defects responsible for this
CsA-induced decrease in K excretion have not been well-
defined. Discretionary control of total body K" balance takes
place in the cortical collecting tubule (CCT) [8—10]. The major-
ity cell type in mammalian CCT is the principal cell which
secretes K4' and reabsorbs sodium and chloride. While the K"
uptake step in mammalian CCT principal cells is accompLshed
via the basolateral membrane Na"/K4'-ATPase, luminal K"'
secretion ultimately occurs via the apical membrane K' chan-
nel [8—10]. We have previously characterized a low conduc-
tance (13 pS for outward current at resting membrane poten-
tial), Ba2"-sensitive K4' channel with high open probability
(>0.8) in the principal cell apical membrane of rabbit CCT
primary cultures [8]. Several groups have documented that this
apical K" conductance is responsible for the physiologic K
secretion observed in macroscopic ion transport studies of
isolated perfused mammalian CCT [8—16].
In the present study we use patch clamp technology to
investigate the effects of basolateral CsA on luminal K" secre-
tion via the 13 pS K4' channel in principal cell apical membranes
of rabbit CCT primary cultures. CsA is a lipophilic, cyclic
peptide which interacts with membrane phospholipids and
alters transmembrane signal transduction [1, 2]. Therefore, the
role of phospholipase C (inositol polyphosphates, cytosolic
Ca24', protein kinase C) and adenyl cyclase (cAMP, protein
kinase A) signaling cascades in the regulation of low conduc-
tance K4' channels by CsA was also examined.
Methods
Preparation of rabbit cortical collecting tubule primary
cultures
Kidneys were dissected from New Zealand white rabbits (1 to
2 kg). Renal cortices were separated and subjected to enzymatic
digestion with type I collagenase (Sigma Chemical Co., St.
Louis, Missouri, USA) for 45 to 60 minutes at 37°C (equilibrat-
ed with 4% CO2 in air) as previously described [8, 17—20].
Cortical collecting tubule fragments were separated by high
speed centrifugation (15,000 to 30,000 x g) in an isotonic
mixture of 50% Percoll and saline. Cortical collecting tubule
fragments, contained in the lower part of the Percoll Fl
separation band, were plated at confluent density on permeable,
glutaraldehyde-fixed collagen films attached to the bottoms of
974
Ling and Eaton: Inhibit ion of renal K channels by CsA 975
small lucite rings [8, 18—20]. This sided preparation allowed
patch pipette access to the apical membrane, and separate
control of the apical and basolateral bath compositions. Cul-
tures were incubated in RK-l medium [50% Ham's F-12 (by
volume) and 50% Dulbecco's modified Eagle's medium (high
bicarbonate and glucose) supplemented with 5 mg/liter trans-
ferrin, 5 mg/liter insulin, 0.05 LM sodium selenite, 0.05 M
hydrocortisone, and 1.5 JiM aldosterone (Sigma Chemical Co.,
MO), pH 7.4] at 37°C and gassed with 4% CO2 in air. Penicillin
(100 U/ml) and streptomycin (100 Jig/mi) were present for the
first 24 to 48 hours. Patch voltage clamp experiments were
performed on confluent CCT monolayers after 5 to 10 days at
37°C.
Patch clamp recording and analysis
Cell-attached patches were established on the polygonal
shaped, principal cells of rabbit CCT culture monolayers as
previously described [8, 18]. Patch pipette and extracellular
bath solutions consisted of a physiologic saline [in mM: 140
NaC1 (final NaCl concentration after titration to pH 7.4 with
NaOH), 5 KC1, 1 CaCl2, 1 MgCl2, and 10 HEPES]. Unitary
channel events were measured using a List EPC-7 Patch Clamp
(Medical Systems Corp., New York, USA), digitized by a DAS
601 Pulse Code Modulator (Dagan Corp., Minnesota, USA) and
recorded on a SL-HF86OD video cassette recorder (Sony Corp.
of America, New Jersey, USA). Data were acquired using a
9O2LPF 8-pole Bessel filter (Frequency Devices Inc., Massa-
chusetts, USA), TL-2 acquisition hardware and Axotape soft-
ware (Axon Instruments Inc., California, USA).
The convention for applied voltage to the apical membrane
patch (— Vpipet) represents the voltage deflection from the patch
potential (that is, resting membrane potential for cell-attached
patches) and is expressed as the potential of the cell interior
with respect to the patch pipette interior (negative values
hyperpolarization; positive values = depolarization). Outward
current (cell to pipette) is represented as upward transitions in
single channel records.
Analysis of data was performed on a 4865X computer (Mit-
suba Southeast Inc., Georgia, USA) utilizing locally and com-
mercially developed software [8, 18]. The total number of
channels (N) in the patch was estimated by observing the
number of observable current levels or the number of peaks
detected on current amplitude histograms. As a measure of
channel activity, NP0 (number of channels times the open
probability) was calculated.
n
NP0=
nQ
T is the total record time, n is the number of channels open and
t, is the record time during which n channels are open.
Since the present and previous patch clamp studies of apical
secretory K channels in the mammalian CCT principal cell
have consistently shown multiple observable current levels (N)
[9—16], NP0 was used as the most accurate measure of channel
activity. NP0 can be calculated without making assumptions
about the total number of channels in a patch or the open
probability of a single channel. If experimental maneuvers (that
is, CsA) produced a great decrease in P0, the actual number of
channels per membrane patch would be underestimated based
on the observable current levels. Previous studies of multiple
channel events in renal epithelia have outlined this difficulty in
accurately quantitating the individual contributions of N versus
P0 [21, 22]. Because of the occurrence of multiple K channels
which are simultaneously gating within each patch, a detailed
analysis of single channel kinetics (interval histogram-derived
mean open and closed times) pre- and post-CsA would also be
inaccurate. In the present study no cell-attached patches con-
tained only one observable current level (that is, a single K
channel) to facilitate such a kinetic analysis.
Statistics
Data are reported as mean NP0 values one standard
deviation. NP0 was calculated for five consecutive minutes of
cell-attached recording under each experimental condition.
Certain cell-attached patch experiments were conducted in a
paired fashion; data from each patch membrane served as the
control for an experimental manipulation. In this case, the
average change in NP0 for a group of patches, compared before
and after an experimental manipulation, was also analyzed
using the paired t-test (significance P < 0.05) [23]. This
approach reduced the variability in the observations due to
differences in ion channel activity between individual patches
and yielded a more sensitive test than comparing the mean NP0
responses.
Chemicals
Cyclosporin A was obtained from Sandoz Pharmaceuticals
(Piscataway, New Jersey, USA). Bis-(o-aminophenoxy)-
ethane-N ,N ,N' ,N '-tetraacetic acid, tetra (acetoxymethyl)-ester
(BAPTA/AM), arginine vasopressin (AVP), 8-diethylamino-
octyl-3 ,4,5-trimethoxybenzoate (TMB-8), thapsigargin, 4/3-
phorbol- 12-myristate- 13-acetate (PMA), 1 -oleyl-2-acetylglyc-
erol (OAG), 4a-phorbol, D-sphingosine, forskolin and N6,2'-O-
dibutyryladenosine 3' ,5'-cyclic monophosphate (db-cAMP)
(Calbiochem Corp., CA or Sigma Chemical) were of the highest
commercial grade available. Appropriate vehicles (dimethyl
sulfoxide or ethanol) were added to control baths; they caused
no change in K channel activity. Because there is reported to
be direct toxicity to renal tubular primary cultures with Cremo-
phor EL (the commercial vehicle used for CsA) [24], ethanol
was used to dissolve CsA.
Results
We have previously characterized K-permeable channels,
responsible for physiologic K secretion, in the principal cell
apical membrane of mineralocorticoid-stimulated primary cul-
tures of rabbit CCT [8]. The most frequently observed K
channel in the cell-attached configuration has a unitary conduc-
tance of 13.3 1.2 pS for outward current (that is, K
secretion), a PK/PNa permeability ratio of 19:1 and a high open
probability (mean P0 = 0.85 0.16) independent of applied
voltage, and is blocked by luminal barium. We investigated the
effects of basolateral CsA exposure on this apical 13 pS K
channel.
Cyclosporin A inhibits apical secretory K channel activity
Baseline channel activity, measured as mean NP0 (number of
channels x P0) was 2.7 1.1 (N = 29) for the 13 pS K channel
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Table 1. Apical 13 pS K channel responses
Experimental maneuver
CsA
pretreatment ng/mla
Number of cell-attached
patch experiments Mean NP0
% Inhibition of
channel activity"
Control None 29 2,7 1.1 —
Basolateral CsA 500 32 0.84 0.32 69
Intracellular Ca2 chelator 500 8 (10 mi BAPTAIAM) 2.9 0.9 None
Intracellular Ca2 release antagonist
Extracellular Ca2 depletion
500
500
7 (10 ILM TMB-8)
9
1,0 0.2
1.8 0.6
63C
33
Basolateral vasopressin 500 10 (25 flM AVP) 0.17 0.23 94C
Intracellular Ca2 release agonist 500 8 (0.25 M thapsigargin) 0.05 0.09 98C
.
Apical PKC agonist None 8(0.1 M PMA)7 (10 M OAG) 0.99 0.40 63
PKC down-regulation 500 10 (0.1 /.LM PMA x 24 hr) 2.7 1.2 None
Apical PKC antagonist 500 6 (100 .LM D-sphingosine) 1.7 0.8 37
Basolateral vasopressin 500 6 (25 M AVP) 2.2 0.7 19
Basolateral vasopressin 500 8 (250 M AVP) 1.7 0.9 37
Abbreviations are: CsA, cyclosporin A; BAPTA/AM, bis-(o-aminophenoxy)-ethane-N,N,N',N-tetraacetic acid, tetra (acetoxymethyl)-ester;
TMB-8, 8-diethylamino-octyl-3,4,5-trimethoxybenzoate; AVP, arginine vasopressin; PMA, 4B-phorbol-l2-myristate-13-acetate; OAG, l-oleyl-2-
acetylglycerola Rabbit CCT cultures were pretreated with CSA in the basolateral bath for 30 minutes prior to cell-attached patching
b Inhibition is the decrease in mean NP0 for experimental maneuver relative to mean NP0 for control (C P <0.05)
in cell-attached patches (Table 1, Fig. 1A). Cell-attached patch
recordings could be routinely maintained for 15 to 30 minutes
without "run-down" of baseline channel activity. After estab-
lishing cell-attached patches, acute application of 250 ng/ml
(N = 5) or 500 ng/ml (N = 7) CsA to the basolateral bath for
five minutes had no affect on K channel activity (mean NP0 =
2.4 1.3). Comparing data obtained from each patch before
and after acutely adding CsA, the average change in NP0 was
not significant by paired 1-testing (Methods).
Although acute exposure had no effect, one cell-attached
patch was very stable and allowed us to observe that K
channel activity did decrease after a 20 minute exposure to 500
ng/ml CsA (Figs. 1A and 2). Therefore, we next applied CsA
(250 or 500 nglml) to the basolateral bath of rabbit CCT primary
cultures for 30 minutes prior to cell-attached patch formation
(Fig. 1A). Pretreatment with 250 nglml CsA did not change K
channel activity (mean NP0 = 2.5 0.9; N = 9), but activity fell
by 69% (mean NP0 = 0.84 0.32; N = 32) after exposure to 500
nglml CsA for 30 minutes. The current-voltage (I-V) relation-
ship for this apical K channel was not altered or shifted by the
latter maneuver, indicating that single channel conductance, ion
selectivity, apical membrane potential and reversal potential
did not change after CsA exposure (Fig. lB). Several intracel-
lular signaling pathways known to regulate apical secretory K
channels in mammalian principal cells are possible candidates
for mediating this CsA-induced K channel inhibition.
CsA -induced K" channel inhibition is dependent on cytosolic
Ca2 +
CsA triggers an increase in cytosolic Ca2"' in renal tubular
epithelial, mesangial, vascular smooth muscle, and platelet cells
[1, 2, 25—27]. Therefore, we investigated whether cytosolic
Ca2"' also plays an essential role in the modulation of renal
secretory K channels by CsA.
Rabbit CCT primary cultures were pretreated by adding both
500 nglml CsA and a cell-permeable intracellular Ca2 chelator,
10 mM BAPTA/AM, to the basolateral bath for 30 minutes prior
to patching [28]. CsA-induced inhibition of 13 pS K channel
activity was abolished when cytosolic Ca2 was buffered (mean
NP0 = 2.9 0.9; N = 8; Fig. 3). Another set of cultures was
pretreated with 500 ng/ml basolateral CsA, but this time CaCI2
was removed from the usual apicallbasolateral bath saline for 30
minutes prior to patching (Methods) (Fig. 3). In the nominal
absence of extracellular Ca2"', inhibition of the K channel by
CsA was also prevented (mean NP0 = 1.8 0.6; N = 9).
Finally, cultures were pretreated by adding both 500 nglml CsA
and an inhibitor of intracellular Ca2"' store release, 10 LM
TMB-8, to the basolateral bath for 30 minutes prior to study [29]
(Fig. 3). Despite the presence of TMB-8, CsA-induced reduc-
tion of mean NP0 (1.0 0.2; N = 7) was preserved. In the
absence of CsA, mean NP0 after 30 minutes of preincubation
with BAPTA/AM alone (2.3 0.8; N = 5), TMB-8 alone (2.3
1.1; N = 4) or Ca2" free extracellular bath (3.0 0.3; N = 4)
was not significantly different from basal apical K" channel
activity in untreated rabbit CCT cultures. Therefore, basolat-
eral CsA alone appears to modulate apical K"' channel activity
through a rise in cytosolic Ca2 that was influenced by extra-
cellular rather than intracellular sources of Ca2" [2].
Release of intracellular Ca"' stores potentiates CsA -induced
K channel inhibition
In renal tubular epithelial, mesangial, vascular smooth mus-
cle and platelet cells, CsA acts predominantly to augment the
biphasic increase in cytosolic Ca2 seen in response to Ca2-
mobilizing vasoactive agonists, such as vasopressin [2, 25, 26].
We noted that exposure to 500 nglml CsA alone (basolateral
bath) for 30 minutes decreased mean NP0 for the 13 pS K"'
channel to 0.84 0.22 (N = 32). Using 10 of these cell-attached
patches as their own controls, subsequent exposure to 25 nM
AVP added to the basolateral bath potentiated the inhibitory
effects of CsA (mean NP0 = 0.17 0.23; Figs. 4 and 5).
Comparing each patch before and after 25 flM AVP addition, the
mean change in NP0 was significant by paired 1-testing. In
isolated rabbit CCT, V1 receptor activation leading to 1P3-
dependent intracellular Ca2 release and activation of protein
kinase C, occurs with exposure to 23 nrvi vasopressin (AVP)
[30]. Thapsigargin is a cell-permeable compound which, unlike
nanomolar AVP, releases intracellular Ca2 stores through an
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I
No Acute Subacute CsA
CsA GsA 250 500
(ng/mI)
1P3-independent mechanism [31]. Cell-attached patches on cul-
tures pretreated with 500nglml basolateral CsA for 30 minutes
were again used as their own control. This time the cultures
were acutely exposed to 0.25 LM thapsigargin in the basolateral
bath and the CsA-induced reduction in NP0 (0.05 0.09; N
8) was again augmented (Figs. 4 and 5). The same conclusion
was reached in a paired comparison. In the absence of CsA,
release of intracellular Ca2 stores by either 25 nai AVP (mean
NP0 = 2.1 0.6; N = 5)or thapsigargin (mean NP0 = 2.1 0.6;
N = 4) alone tended to reduce basal K channel activity, but
the change was not statistically significant.
Ca2 k-dependent protein kinase C mediates K channel
inhibition by CsA
Potential candidates for mediating the effect of cytosolic
Ca2 on apical K permeability could be Ca2-activated en-
zymes such as phospholipid-dependent protein kinase C (PKC)
[9-11].
In the absence of CsA, PKC activity was stimulated by
application of 0.1 sM phorbol ester, PMA (N = 6), or 10 tM
synthetic diacylglycerol, OAG (N = 5), to the basolateral
surface of rabbit CCT cultures for 15 minutes. There was no
consistent inhibition of 13 pS K channel activity (mean NP0 =
2.9 1.3). In contrast, in the absence of CsA, apical application
of 0.1 j.M PMA (N = 8), or 10 jiM OAG (N = 7) for 15 minutes
prior to patching decreased mean NP0 to 0.99 0.40 (Fig. 6A).
Similar to CsA-induced K channel inhibition, the I-V relation-
ship was unaffected by either apical PMA or OAG (Fig. 6B).
Apical membrane exposure to 0.1 jiM inactive phorbol ester,
4a-phorbol, had no effect on K channel activity (N = 6).
We also performed experiments on a separate set of CsA-
pretreated rabbit CCT cultures in which PKC activity was
down-regulated by 24 hour exposure to 0.1 jiM apical PMA
(Fig. 6). Under these conditions, K channel inhibition by CsA
was not observed (mean NP0 = 2.7 1.2; N = 10). To
determine if the effect of basolateral CsA exposure was medi-
ated by PKC activity localized at the apical membrane, we
established cell-attached patches on CsA-pretreated cultures
exposed to the PKC antagonist, 100 jiM D-sphingosine, in the
apical bath for 30 minutes [32] (Fig. 6). PKC antagonism also
eliminated the inhibitory effect of CsA (mean NP0 = 1.7 0.8;
N = 8). Despite the presence of CsA, mean NP0 after these two
PKC inhibiting maneuvers was not statistically different from
channel activity under control conditions. In the absence of
CsA, mean NP0 after D-sphingosine exposure (2.8 1.1; N =
6) was also not significantly different from control channel
activity.
Increases in cyclic AMP attenuates CSA-induced K channel
inhibition
Another intracellular signaling cascade implicated in the
regulation of apical secretory K channels in mammalian
principal cells involves cyclic AMP [10, 11, 16].
Rabbit CCT cultures unexposed to CsA were pretreated with
the adenyl cyclase agonist, forskolin (10 jiM) in the basolateral
bath for 30 minutes. Mean NP0 (3.1 0.4; N = 5) for the 13 pS
K channel increased in cell-attached patches after forskolin,
but did not reach statistical significance (Fig. 7). However,
basolateral pretreatment with the cell permeable cAMP ana-
logue, 0.5 mri db-cAMP for 30 minutes stimulated apical K
channel activity by 59% (mean NP0 = 4.3 0.9; N = 8) over
baseline.
Ando, Breyer and Jacobson [30] have described the dose-
dependent effects of AVP on isolated rabbit CCT. At 23 M or
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Fig. 1. Effect of GsA exposure on apical 13 p5 K channels. (A)
Baseline channel activity (NP0 calculated from 3 to 5 mm of continuous
recording) is shown for control cell-attached patches on rabbit CCT
cultures unexposed to CsA (0). Using control patches as their own
controls, NP0 was then calculated for the 5 minutes immediately
following the addition of either 250 ng/ml (0) or 500 ng/ml (0) CsA to
the basolateral bath. Symbols connected by lines represent data from
the same patch. A separate set of cultures was preincubated with either
250 ng/ml (Lx) or 500 ng/ml (V) CsA in the basolateral bath for 30
minutes prior to patching. Mean NP0 1 SD is also represented for each
experimental maneuver. All data were obtained at resting membrane
potential (Vpipet = 0 mY). (B) Current-voltage (I-V) relationship.
Mean channel amplitude for cell-attached patches is plotted versus
negative applied potential (—V1j. The I-V curve for cell-attached
patches with 140 NaCII5 KCI in the pipettes reveals a reversal potential
—48 mV and an outward conductance of 13 PS near resting
membrane potential in the absence of CsA exposure (0; N = 29) or
after 30-minute basolateral exposure to 500 ng/ml CsA (V; N = 32).
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200 sec
Fig. 2. Effect of subacute exposure to CsA. Lower trace: cell-attached recording shows progressive decline in K channel activity for the 30
minutes immediately following the addition of 500 ng/ml serosal CsA (arrowhead). Upper traces: two portions of the recording have been enlarged
to better appreciate the relative decrease in activity. app was 0 mV and the original corner frequency (Fc) was I KHz for all single channel records.
The enlarged portions were additionally software filtered at 300 Hz.
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Fig. 3. Role of calcium in CsA -induced K channel inhibition. Control
channel activity is depicted again for comparison (0). Cultures were
exposed to 500 ng/ml CsA for 30 minutes under conditions of intracel-
lular Ca2 buffering by 10 m BAPTA/AM (0; N = 8), extracellular
bath Ca2 removal (V; N = 9), or blockage of intracellular Ca24 store
release with 10 M TMB-8 (Lx; N = 7). BAPTA/AM abolished, bath
Ca24 removal attenuated, and TMB-8 had no effect on CsA-induced
channel inhibition.
230 M AVP, V2 receptor stimulation predominates over V1
leading to adenyl cyclase activation and increased cAMP levels.
In contrast to the enhanced K4 channel inhibition we observed
No GsA
Subacute GsA, 500 ng/ml
1.5
1.0
0.5
0.0
Fig. 4. Effect of intracellular Ca store release on GsA-induced
channel inhibition. Control activity (0) and inhibition by 30 minute
exposure to 500 ng/ml CsA alone is depicted for comparison (V). Using
CsA-exposed patches as their own controls, NP0 was measured for the
5 minutes immediately following addition of either 25 nM AVP (Lx; N =
10)or 0.25 M thapsigargin (; N 8) to the basolateral bath. Symbols
connected by lines represent data from the same patch. Both agents
potentiated the inhibitory effects of CsA.
with high dose (25 nM) AVP above, basolateral exposure to 25
M (mean NP0 = 2.2 0.7; N = 6) or 250 M AVP (mean NP0
= 1.7 0.9; N = 8) reversed the K channel inhibition which
CGsA 500 ng/mI pretreatment (30 mm)
Figure 5. Effect of intracellular Ca'- store release after GsA pretreatment. Cell-attached patch recordings show additional channel inhibition
associated with either acute serosal exposure to 25 flM AVP (A) or 0.25 M thapsigargin (B).
followed a 30-minute basolateral exposure to 500 nglml CsA
(Figs. 7 and 8). Using each patch as its own control, the change
in NP0 before and after picomolar AVP was significant by
paired t-testing.
Discussion
Hyperkalemia during cyclosporin A therapy is a major clini-
cal problem for patients with organ transplantation or autoim-
mune diseases [71. Human and animal studies have documented
a decrease in both kaliuresis and urinary acidification with CsA
therapy, suggesting that the drug may interfere with distal
nephron ion transport [3—6]. Using patch clamp methodology,
we investigated the effect of basolateral CsA exposure on the
low conductance K channel, which is located in the principal
cell apical membrane of mammalian CCT and is responsible for
physiologic K secretion (Table 1) [8—16].
GSA inhibits apical 13 pS K channels in rabbit principal
cells
Inhibition of the total apical secretory K conductance ('K) in
the mammalian principal cell by CsA could occur through
changes in NP0 (number of channels times open probability),
channel conductance (g), or the electrical driving force
(Va — EK), where Va is the apical membrane potential, and EK
is the K channel's reversal potential.
'K = gK NP0 (Va — EK)
We found that pretreatment (30 mm), but not acute exposure
(5 mm) to basolateral CsA resulted in a significant 69% reduc-
tion in NP0 for the apical, 13 pS K channel at concentrations
of 500 ng/ml, while 250 nglml had no effect. CsA-induced
changes in intracellular Ca2 signaling in renal epithelial, me-
sangial and vascular smooth muscle cells are similarly time- and
dose-dependent [2, 25—27].
Tumlin and Sands [33] have also noted a dose-dependent
effect of CsA on ion transport in isolated rat CCT. They found
that inhibition of Na/K-ATPase activity occurred after 30
minutes of exposure to CsA at concentrations  600 nglml, but
not at 300 nglml. Wang and associates [10—12] have established
that apical secretory K channels in rat CCT are inhibited by an
increase in the ATP/ADP ratio (normal = 3.1 to 5.8). Na/K-
ATPase inhibition increases the ATP/ADP ratio from 3 to 6 in
rabbit cortical tubules [11]. Direct measurement of ATP/ADP
levels and their effects on CCT K channels in the presence of
CsA have not been performed. CsA-induced Na/K-ATPase
inhibition would also be expected to decrease intracellular K
content, reducing the electrochemical driving force for luminal
K secretion through apical secretory K channels. However,
the current-voltage relationship for the 13 pS K channel was
not altered or shifted by CsA, indicating that changes in single
channel conductance (g), ion selectivity, apical membrane
potential (Va) and reversal potential (EK) do not significantly
contribute to channel inhibition. In preliminary studies in rabbit
CCT cultures, we have shown that Na/K-ATPase inhibition
with 100 jsM ouabain alone reduces mean NP0 for the 13 pS K
channel by 32%, while exposure to both ouabain and 500 nglml
CsA reduced mean NP0 by an additional 51% [34]. The same
dose of ouabain (100 sM) has been shown to rapidly depolarize
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Fig. 6. Role of apical membrane protein kinase C in GsA-induced
channel inhibition. (A) Control channel activity is depicted again for
comparison (0). Application of PKC agonists, 0.1 iLM PMA (V; N = 8)
or 10 LM OAG (; N = 7), to the apical bath of cultures unexposed to
CsA results in channel inhibition. Down-regulation of PKC activity by
24 hour exposure to 0.1 MM apical PMA (0; N = 10) or pretreatment
with a PKC antagonist, 100 MM D-sphingosine (; N = 8) attenuates
the usual CsA-induced channel inhibition. (B) Comparing I-V curves,
apical exposure to PMA (V; N = 8) or OAG (Lx; N = 7) produced no
significant change from control conditions (Fig. lB).
freshly dissected rabbit CCT, actually reversing the transepi-
thelial potential from —39.7 to 5.7 my [351. Therefore, while
changes in the electrochemical driving force (Va— EK) due to
Na/K-ATPase inhibition could contribute to CsA-induced
decreases in apical K secretion, they cannot entirely explain
our observed reduction in apical K channel activity (NP0).
Cytosolic Ca is required for CsA -induced K channel
inhibition
How does CsA change renal epithelial K channel activity?
CsA is a lipophilic, cyclic peptide which interacts with mem-
brane phospholipids and is, therefore, capable of affecting
several intracellular signal transduction cascades [1, 2]. Ca2
signaling in mammalian renal cells (rat cortical epithelial cells,
II
I 1L
No GsA Subacute GsA, 500 ng/ml
Fig. 7. Effect of adenyl cyclase activation on K channels and GsA-
induced inhibition. Control channel activity is depicted again for
comparison (0). Application of the adenyl cyclase agonist, 10 MM
forskolin (0; N = 5) or cell-permeable cAMP analogue, 0.5 mM
db-cAMP (0; N = 8) to the serosal bath of cultures unexposed to CsA
results in stimulation of baseline channel activity. Using CsA-exposed
patches as their own controls, NP0 was measured for the 5 minutes
immediately following addition of either 25 M (; N = 6) or 250 pM
AVP N = 8) to the basolateral bath. Symbols connected by lines
represent data from the same patch. Both agents partially reversed the
inhibitory effects of CsA.
dog kidney epithelial cell line, glomerular mesangial cells) and
non-renal cells (vascular smooth muscle cells, platelets) is
consistently affected by CsA, causing a sustained influx of
extracellular Ca2 [2, 25—271. Therefore, we investigated
whether transduction of CsA-mediated K channel inhibition
was dependent on intracellular Ca2 responses.
BAPTA/AM is a cell permeable compound that is trapped
intracellularly and hydrolyzed by cytosolic esterases to form
the active Ca2 chelator, BAPTA [28]. Cytosolic free Ca2
levels are lowered to 4.6 X iO4 M by 10 m intracellular
concentrations of BAPTA [361. We found that pretreatment
with BAPTA/AM alone neither stimulated nor inhibited base-
line K channel activity, suggesting that basal cytosolic Ca2
levels in the principal cell do not inhibit steady-state luminal K
secretion. However, pretreatment with 10 m'vi BAPTA/AM
abolished the CsA-induced inhibition of 13 pS K channel
activity. K channel inhibition by CsA was also abolished by
removal of extracellular bath Ca2. However, inhibition of
Ca2 release from 1P3-sensitive, intracellular stores by TMB-8
failed to significantly attenuate the effects of CsA [29]. Simi-
larly, in non-epithelial cells, CsA does not appear to directly
stimulate phospholipase C, or generate diacylglycerol and in-
ositol polyphosphate metabolites [2]. These experiments sug-
gest that the initial rise in cytosolic Ca2 induced by basolateral
0
8
8
D
0
Kj
A
4.0
3.5
3.0
2.5
0 20z
1.5
1.0
0.5
0.0
1.4
1.0
0.6
0.2
—0.2
—0.6
—1.0
CD8
CD
z
T
0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0 -
0
8
Unit conductance 13 pS
—140 —100 —60 —20 20 60
03
02
01
C
Ling and Eaton: Inhibition of renal K channels by CsA 981
I 0.5 pA
200 sec
Fig. 8. Effect of picomolar AVP on CsA-induced channel inhibition. In cultures pretreated with 500ng/ml CsA, cell-attached patch recording
shows reversal of channel inhibition by acute serosal exposure to 25 M AVP.
CsA, is due to enhanced extracellular Ca2 influx rather than
intracellular Ca2 release.
Ca2 k-mobilizing vasoactive agonists augment CsA effects
CsA accumulates in cell membranes and alters the lipid-
protein interactions which promote extracellular Ca2 influx via
conductive pathways [2]. The majority of this CsA-induced
Ca2 entry is sequestered into intracellular pools. In renal
tubular epithelial cells, glomerular mesangial cells and vascular
smooth muscle cells preincubation with CsA augments the
biphasic increase in cytosolic Ca2 (initial release of intracel-
lular Ca2 stores and sustained extracellular Ca2 entry) seen
following exposure to vasoactive agents (that is, vasopressin,
angiotensin II, endothelin, platelet-derived growth factor, cat-
echolamines) [2, 25, 26]. Since acute CsA nephrotoxicity in-
volves both renal vascular and tubular effects, and Ca2-
mobilizing vasoactive agonists are known to modulate both
renal hemodynamics and tubular ion transport [21, we investi-
gated the effect of vasopressin (AVP) on CsA-induced K
channel inhibition.
We found that acute exposure to 25 nM AVP augmented
CsA-induced inhibition of the 13 pS K channel in rabbit
principal cells. Stimulation of vasopressin V1 receptors in rabbit
principal cells increases inositol polyphosphate production via
coupling to a pertussis toxin-sensitive G-protein and results in
raised cytosolic free Ca2 levels [37]. Thapsigargin is a cell-
permeable tumor promoter that directly releases intracellular
Ca2 pools without hydrolysis of inositol polyphosphates [31].
When we exposed CsA-pretreated cells to thapsigargin, channel
inhibition was also augmented in a manner similar to 25 nri
AVP. In contrast, no significant channel inhibition was induced
by nanomolar AVP or thapsigargin alone, in the absence of
CsA. Therefore, similar to their synergistic effects on renal
vascular hemodynamics, Ca2-mobi1izing vasoactive agonists
also appear to augment CsA-induced inhibition of principal cell
K transport.
Consistent with our findings, Jacobson and associates [30]
found that V1 receptor activation, leading to increased cytosolic
Ca2 and activation of protein kinase C, occurred with similar
concentrations of AVP (23 nM). However, they also found that
the effects of AVP on isolated rabbit CCT were dose-depen-
dent. At 23 M or 230 M AVP, V2 receptor stimulation
predominated leading to adenyl cyclase activation and in-
creased cAMP levels. Interestingly, we found that acute expo-
sure of CsA-pretreated rabbit CCT cultures to 25 M or 250 M
AVP reversed, rather than enhanced the CsA-induced K
channel inhibition. Supporting a role for cAMP in the effects of
picomolar AVP, we found that stimulation of adenyl cyclase
with forskolin or application of a cell-permeable cAMP ana-
logue stimulated baseline 13 pS K channel activity. Wang and
associates have described stimulation of the apical secretory
K channel in rat CCT by AVP in the 110 to 220 M dose range
or by direct application of cAMP-dependent protein kinase A to
excised inside-out patches [10, 11, 16]. The fact that circulating
AVP levels for rabbits, rats, dogs and humans are also in the
picomolar range suggests that these cAMP-induced effects at
lower AVP concentrations may reflect the more physiologic
response [30].
Breyer [38] has recently shown in isolated rabbit CCT that
cAMP stimulates apical Na entry, secondarily activating the
basolateral Na/Ca2 exchanger and increasing intracellular
Ca2 levels. In our rabbit CCT culture preparation, the direct
stimulatory effect of cAMP-stimulated PKA must offset any
potential inhibitory effects of cAMP-stimulated Na/Ca2 ex-
change on apical K channel activity.
CsA -induced K channel inhibition is mediated by Ca-
dependent protein kinase C
Despite the apparent role of cytosolic Ca2 in K channel
inhibition, we have previously shown that the P0 for the 13 pS
K channel is not altered by directly increasing the free Ca2
concentration (10—u to 10 M) bathing the cytoplasmic surface
of excised inside-out patches [8]. Therefore, the preceding data
suggest that basolateral CsA-induced effects on apical K
channels are modulated indirectly by a Ca2-dependent inter-
mediate signal. Raising epithelial intracellular Ca2 with carba-
chol or Ca2 ionophore results in translocation of PKC from the
cytosolic to apical membrane fraction within one minute [39,
40]. Exposure of rabbit CCT cultures to the phorbol ester, PMA
or synthetic diacylglycerol, OAG also promotes translocation
of PKC from the soluble to membrane fraction within minutes
[41]. Similarly, CsA activates PKC by inducing a rapid trans-
location of PKC from the cytosol to the membrane in vascular
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V
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Fig. 9. Mode/for inhibition of principal cell
apical secretory K channels by CsA.
Subacute exposure to serosal CsA mediates
extracellular Ca2 entry through an as yet
unknown pathway (upper). This influx
increases basal intracellular [Ca2]1 levels and
is sequestered into intracellular Ca2 pools.
Elevations in [Ca2]1 promote the
translocation of cytosolic protein kinase C to
the apical membrane. Ca2 and membrane
plospholipids activate PKC and inhibit apical
K channels. Nanomolar concentrations of
vasopressin potentiate this inhibitory cascade
by releasing 1P3-sensitive [Ca2]1 stores.
Physiologic picomolar concentrations of
vasopressin attenuate CsA-induced inhibition
through the stimulatory effects of cAMP-
dependent protein kinase A.
smooth muscle cells and platelets [26, 39—41]. Previous studies
of renal epithelial PKC activity after exposure to CsA have
shown an increase in phorbol ester receptors in rat renal
medulla membrane preparations [42] and a reduction in the
cytosolic PKC fraction in Madin-Darby canine kidney cells
[43].
We found that the apical 13 pS K channel in rabbit CCT
cultures was also inhibited after activation of Ca2-dependent
PKC by phorbol esters or synthetic diacyiglycerols. However,
there was a sidedness to this K channel inhibitory response,
with the effect occurring only with apical, but not with basolat-
eral application of the PKC agonists. This suggests that apical
membrane bound PKC is responsible for modulating the apical
13 pS K channel. Consistent with this premise, studies by
Wang and Giebisch [10, 11] also show inhibition of apical K
secretory channels in rat CCT by direct application of PKC to
the cytoplasmic surface of excised inside-out patches.
D-sphingosine is an endogenous PKC antagonist that com-
petitively interacts with diacylglycerol and Ca2, and affects
the regulatory domain of PKC [32]. When we blocked the
effects of apical membrane PKC by apical pretreatment with
D-sphingosine, CsA-induced K channel inhibition was elimi-
nated. Similarly, when PKC activity was down-regulated by
prolonged apical exposure to phorbol esters, K channel inhi-
bition by CSA was also abolished. Incubation with D-sphin-
gosine or chronic phorbol esters alone neither stimulated nor
inhibited baseline K channel activity, suggesting that tonic
apical membrane PKC activity in the principal cell plays little
role in steady-state luminal K secretion.
The I-V relationship for the apical secretory K channel was
unaffected by either basolateral CsA, or apical PMA or OAG,
suggesting that CsA-induced inhibition through PKC is not
mediated through changes in single channel conductance, ion
selectivity or apical membrane potential or reversal potential.
We would have expected the apical membrane potential to
depolarize and shift the I-V relationship if PKC affected only
apical secretory K channels. However, we have previously
shown that Ca2-dependent activation of apical PKC also
inhibits the apical Na channel responsible for principal cell
Na reabsorption [20, 44]. Hays, Baum and Kokko [45] have
shown that both macroscopic K secretion and Na reabsorp-
tion in isolated perfused rabbit CCT are reduced after activation
of protein kinase C.
Conclusions
Human studies suggest that tubulointerstitial damage and
insensitivity of cortical collecting tubules to aldosterone (that
is, type IV renal tubular acidosis) are responsible for the
hyperkalemia and distal tubular acidification defects observed
with chronic CsA therapy [7]. However, these authors hypoth-
esized that an intrinsic tubular defect in K secretion due to
either a reduction in "favorable electrochemical gradient" (that
is, basolateral Na/K pump activity) or a reduction in "con-
ductance for K" (apical K channel activity) might also
contribute to the hyperkalemic effects of CsA.
Because the 13 pS K channel has high basal activity (P0>
0.8), CsA-induced inhibition of this luminal K conductance
could indeed affect renal tubular K secretion (Fig. 9). We have
shown that serosal exposure to 500 ng/ml CsA for 30 minutes
results in a 69% reduction in the activity of luminal membrane
13 p5 K channels responsible for physiologic K secretion in
mammalian CCT principal cells. Since renal tissue CsA levels
have been shown to be concentrated anywhere from 3-fold [46]
to 190-fold [47] above whole blood CsA levels, our findings
likely contribute to the clinically observed decreases in kaliure-
sis seen with "therapeutic" serum CsA levels ( 200 nglml).
Inhibition of K channel activity is mediated by enhanced Ca2
influx, increased cytosolic Ca2 and activation of apical protein
kinase C. Basolateral exposure to pharmacologically-high Va-
sopressin levels (25 nM) augments CsA-induced K channel
inhibition, probably through release of intracellular Ca2
stores, while more physiologic vasopressin levels (25 to 250 pM)
Ling and Eaton: Inhibition of renal K channels by CsA 983
attenuates CsA-induced K channel inhibition, probably
through activation of adenyl cyclase.
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